Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (61-70 of 910) with videos related to

Pageof 91
Sort By:
Journal of the American College of Cardiology|October 18, 2014
Another biomarker for risk assessment in acute myocardial infarction?Christopher B Granger, Thomas J Povsic
European Heart Journal|February 8, 2020
Managing patients with ST-elevation myocardial infarction and multivessel disease: is the story complete?Jennifer A Rymer, Christopher B Granger
JACC. Cardiovascular Interventions|June 21, 2014
Assessing oral beta-blocker therapy after percutaneous coronary intervention for ST-segment elevation myocardial infarction: the role of observational dataChristopher B Granger, Meena P Rao
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Practical advice on safe and effective use of non-vitamin K antagonist oral anticoagulantsSean D Pokorney, Christopher B Granger
Annals of Internal Medicine|May 2, 2022
In older persons at risk for dementia, a multidomain approach reduced stroke and transient ischemic attackKonstantin A Krychtiuk, Christopher B Granger
Annals of Internal Medicine|October 19, 2020
In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrelMichael G Nanna, Christopher B Granger
Circulation. Cardiovascular Quality and Outcomes|March 1, 2021
Standardizing ST-Segment Elevation Myocardial Infarction Care: Customizing Regionalization to Improve OutcomesJosephine L Harrington, Christopher B Granger
JAMA Cardiology|July 21, 2016
Understanding the Adverse Effects of Ticagrelor in PracticeChristopher B Granger, Peter B Berger
Annals of Internal Medicine|May 3, 2021
LOW-HARM score predicted mortality in patients hospitalized with COVID-19 in MexicoMichelle D Kelsey, Christopher B Granger
Circulation|November 6, 2023
The Need for Randomized Trials to Define the Optimal Dose of Anticoagulants for Atrial Fibrillation in Chronic Kidney DiseaseSean D Pokorney, Christopher B Granger
Pageof 91

Showing results (61-70 of 910) with videos related to

Sort By:
Pageof 91
Journal of the American College of Cardiology|October 18, 2014
Another biomarker for risk assessment in acute myocardial infarction?Christopher B Granger, Thomas J Povsic
European Heart Journal|February 8, 2020
Managing patients with ST-elevation myocardial infarction and multivessel disease: is the story complete?Jennifer A Rymer, Christopher B Granger
JACC. Cardiovascular Interventions|June 21, 2014
Assessing oral beta-blocker therapy after percutaneous coronary intervention for ST-segment elevation myocardial infarction: the role of observational dataChristopher B Granger, Meena P Rao
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Practical advice on safe and effective use of non-vitamin K antagonist oral anticoagulantsSean D Pokorney, Christopher B Granger
Annals of Internal Medicine|May 2, 2022
In older persons at risk for dementia, a multidomain approach reduced stroke and transient ischemic attackKonstantin A Krychtiuk, Christopher B Granger
Annals of Internal Medicine|October 19, 2020
In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrelMichael G Nanna, Christopher B Granger
Circulation. Cardiovascular Quality and Outcomes|March 1, 2021
Standardizing ST-Segment Elevation Myocardial Infarction Care: Customizing Regionalization to Improve OutcomesJosephine L Harrington, Christopher B Granger
JAMA Cardiology|July 21, 2016
Understanding the Adverse Effects of Ticagrelor in PracticeChristopher B Granger, Peter B Berger
Annals of Internal Medicine|May 3, 2021
LOW-HARM score predicted mortality in patients hospitalized with COVID-19 in MexicoMichelle D Kelsey, Christopher B Granger
Circulation|November 6, 2023
The Need for Randomized Trials to Define the Optimal Dose of Anticoagulants for Atrial Fibrillation in Chronic Kidney DiseaseSean D Pokorney, Christopher B Granger
Pageof 91